Category: Health

Tobacco Companies Work in Secret to Defeat California’s Proposition 29

A pitched battle is on over California’s Proposition 29, a measure on the statewide ballot to raise the cigarette tax by one dollar to fund smoking cessation and research on tobacco-related diseases. If enacted, the measure would increase California’s per-pack cigarette tax to $1.87 per pack.  According to Maplight, the biggest donors favoring the tax are the American Cancer Society ($7.42 million), the Lance Armstrong Foundation  ($1.5 million), the American Heart Association ($546,256), the American Lung Association ($412,086) and Michael R. Bloomberg ($500,000). Laurene Powell Jobs, the widow of Steve Jobs, kicked in $25,000 to support Prop. 29. But those amounts pale in comparison to the tidal wave of money tobacco companies and their allies are pouring into defeating the measure. Philip Morris (Altria) alone has given just over $24 million, Reynolds American, Inc. has put in $9.57 million, and U.S. Smokeless (also owned by Altria) has put in $1.5 million. The California Republican Party contributed $1.14 million to defeat the tax. As usual, tobacco companies are trying to hide their role in the campaign by refusing to speak to journalists, running ads without their fingerprints on them and fighting the campaign through a front group, “Californians Against Out-of-Control Taxes and Spending,” which is aligned with right wing, pro-business groups funded by millionaires and billionaires like Americans for Prosperity, FreedomWorks, the Chamber of Commerce and the Petroleum Marketers Association. Californians Against Out-of-Control Taxes and Spending doesn’t even list tobacco companies among the “No” campaign’s endorsers on the group’s website — as if tobacco companies weren’t involved.

Skechers Pays $40 Million for Deceptively Advertising “Butt Toning” Shoes

Kim Kardashian helped market Skechers "toning shoes"

Skechers, the maker of those roly-poly  “toning shoes” that were a big craze back in 2010, will shell out $40 million to settle charges that it deceived consumers with phony claims the shoes conferred health benefits like weight loss, muscle strengthening and butt toning.  Back in 2010, fitness footwear companies like Skechers, Nike and Reebok raked in about $1.1 billion from the “toning shoe” market by charging between $100 and $200 a pair for the shoes. Skechers controlled about 60 percent of the market, and Reebok had about a 33 percent share. The companies created demand for the shoes by running ads that falsely claimed they would help wearers “shape up while you walk” or  “get in shape without setting foot in a gym.” The Federal Trade Commission (FTC) alleged that the shoe manufacturers fudged studies and statistics to make claims about the shoes that they could not support. Last  September, Reebok agreed to pay $25 million to settle charges that it deceptively advertised roly-poly shoes with names like TrainTone, RunTone and EasyTone.  The companies are paying the millions of dollars into a fund to which shoe purchasers can apply for a refund. If you bought Reebok toning shoes, you can click here to apply for a refund. People who fell for Skechers “butt toning” shoe ads and bought them can keep an eye on this website to get refunds when the account it set up.

Main source: Advertising Age, May 16, 2012

“Robin Hood Tax” Proposal Gains Global Support

Nurses rally in Chicago to support the Robin Hood Tax

Nurses led a rally in Chicago May 18 ahead the NATO summit to boost the idea of instituting a “Robin Hood Tax,” a tiny tax on financial institutions’ transactions that would be used to offset drastic cuts in education and social services, and provide health care to Americans. Also called a Financial Speculation Tax, the tax has the support of Warren Buffett and Bill Gates, as well as President Hollande of France, Chancellor Merkel of Germany, Prime Minister Zapatero of Spain and other world leaders, as well as Nobel prize winning economists Joseph Stiglitz and Paul Krugman. The Robin Hood Tax on bankers would be less than one-half of one percent on deals over $100, and would apply to transactions like trades in derivatives, stocks, bonds and foreign currency exchanges. The charge would total less than one half on one cent on every $100 worth of transactions. Most ordinary people worldwide would never feel it, but experts estimate it would generate hundreds of billions of dollars each year to fight poverty and support public services like education and health care. National Nurses United teamed with National Peoples’ Action and local community groups to organize the rally. The were joined by veterans, members of the Occupy Movement, unions and others. The rally was part of a “global week of action” in support of the Robin Hood tax, with rallies also happening in Europe, Africa and on Mount Fuji in Japan.

Clean, Sustainable Energy vs. Fracking Colorado

A guest post by Michele Swensen

The week prior to Senator Morgan Carroll’s May 2 introduction of SB 107 (The Fracking Safety Act) to the Senate Judiciary Committee, an oil drilling site near Windsor, Colorado, operated by Ranchers Exploration Partners based in Greeley, was issued a cease-and-desist order by the Colorado Oil and Gas Conservation Commission (COGCC), which declared an environmental emergency. The site, located in unincorporated Larimer County above the Ridge West residential subdivision, the Poudre River and a lake, was declared a public health hazard after the drilling rig became unstable and brought up potentially toxic solid waste from the landfill upon which it was positioned. The COGCC had issued a drilling permit in September 2010, and state health officials were satisfied that the company had moved the drilling site sufficiently away from the landfill, based on a June, 2011 six-foot test drill over the site. Ranchers Exploration plans to move the drilling rig yet again to another site on the same property, ostensibly away from the old landfill.

The COGCC’s field inspection of the drilling site concluded that Ranchers Exploration failed to follow “most best management practices for drilling sites,” e.g., failing to build secondary containment for “storm water runoff, sewage, chemicals and other toxins that might flow off the drilling pad.”

The Bottled Water Scam

Some beverage companies secretly bottle tap water and then charge 1,900 times more for it

People who buy bottled water pay up to 1,900 times what tap water costs, but get less access to key information about the pricey water than they do for tap water. Big companies that sell bottled water, like Pepsi (Aquafina) and Coke (Crystal Geyser), want you to think their water is special, but refuse to reveal where their water comes from, the methods used to purify it or whether their own testing revealed any contaminants in the water. According to the Environmental Working Group (pdf), the makers of the top ten best-selling brands of bottled water refuse to answer at least one of those questions. Only one — Nestle, maker of Pure Life Purified water — willingly discloses the specific source of its water, treatment method and gives consumers access to a water quality test report. Digging for information reveals that at at least one brand of bottled water, Aquafina, is bottled from a public water source. California passed a law in 2007 ordering bottle water manufacturers to publicly disclose quality information about their bottled water, but as of 2011 only 34 percent of companies were complying with the law. When asked to supply water quality information, the makers of Aquafina claimed it was “proprietary information” that was “not for the public.” Bottled water companies make claims like their water is purely from rainfall, purified by “equatorial winds” (Fiji Water) or can help you live longer, but cannot and do not substantiate these claims. In the mean time, every 27 hours, Americans drink enough bottled water to circle the Earth with plastic bottles stacked end to end. EWG recommends drinking filtered tap water instead of bottled water. Municipalities issue annual tap water quality reports that are always available to the public.

Source: Environmental Working Group report 2011 Bottled Water Scorecard (pdf)

Bizarre Ideas to Sell More Smokes from Philip Morris

This 1987 Philip Morris brainstorming document is full of bizarre ideas for how to make cigarettes more appealing and marketable to consumers, and how to design cigarettes to help counter the social stigma of smoking. Ideas include making cigarettes that deodorize a room, control appetite, alter consciousness, administer an aphrodisiac, mimic certain drugs, emit insect repellant, control cholesterol intake, serve as a laxative, renew energy, and even –amazingly enough — cure cancer (although ironically this last one was one of the very few ideas that was later crossed off the list).

Page 3 contains a brief discussion of how to lure quitters back to smoking: “Someone suggested talking with quitters to discover how we might recover these consumers…” The document also discusses ways to “turn the tables” on the Surgeon General by making a “healthy cigarette,” and ways to make the pack more attractive and useful. Ideas include making the pack into a smoke detector, an alarm clock, a calculator, a “handy mirror,” a “breatholyzer”, or use microchips to make packs that play tunes, or tell smokers how many cigarettes remain in the pack. Another idea was for a “jolt” cigarette that offered extra-high nicotine.  Other ideas included cigarettes that enhance athletic performance and increase lung capacity, or slow formation of wrinkles, a “taco-dorito”- flavored cigarette and a carbonated cigarette that would make the mouth all tingly.

Abbott Labs Pays $1.6 Billion for Illegal Drug Marketing

Abbott Laboratories, the maker of Ensure, PaediaSure, Similac and Vicodin, pled guilty to misbranding and illegally marketing its drug Depakote. Abbott will pay a $1.6 billion fine and undergo five years of probation under an agreement reached with the U.S. Department of Justice in which Abbott admitted that from 1998 to 2006 it kept a separate, specially-trained sales force to market Depakote to nursing homes for the control of aggression and agitation in elderly patients with dementia, even though no credible scientific research existed showing Depakote was effective for that use. Abbott also admitted that from 2001 through 2006 it marketed Depakote for the treatment schizophrenia, in the absence of any proof that the drug was effective for that condition, either. Abbott funded two separate studies on the use of Depakote for schizophrenia, but neither study met its set goals. Abbott took two years to tell its sales force about the failed studies, and in the meantime kept marketing Depakote for schizophrenia. The case against Abbott arose in 2007 when a former Abbott saleswoman filed a lawsuit accusing the company of encouraging  its sales force to illegally promote use of Depakote in nursing homes and publicly-operated mental health centers, where most patients are covered by federal health programs like Medicaid. Whistleblowers also filed suits against Abbott in Virginia, Illinois and the District of Columbia accusing the company of paying illegal kickbacks to doctors and pharmacists to discuss off-label uses of Depakote to increase sales.

Main source: Courthouse News Service, May 7, 2012

Health Insurers Shake Down Subscribers for Prescriptions

Big health insurers have found yet another new way to extort customers — by buying up “pharmacy benefit managers,” (companies that supply medications to people) and then forcing subscribers to buy medications exclusively from the drug distributors they own. People are receiving letters from their health insurance companies telling them they must either buy medications from a specific company they own and get medications through the mail, or patronize a retail drug store of their choice and pay a much higher price. Prices may be lower for insurance companies under this kind of arrangement, but policyholders miss out on face-to-face interaction with pharmacists, who verbally counsel customers on drug dosing instructions and dangerous interactions with other drugs. Herding people towards a single option drug supplier is also taking a toll on neighborhood pharmacies who have been serving the same families for generations. The trend towards consolidation in the drug sales market starkly limits consumer choice. Just three major pharmacy benefit management companies dominate the drug delivery market: Express Scripts Holding, which recently bought Medco for $29 billion, CVS Caremark, and OptumRX, a subsidiary that now belongs to the big health insurance company UnitedHealthcare Group.

Source: Los Angeles Times (consumer advocate David Lazarus), May 4, 2012

Female, African-American Doctor Backs Tobacco Industry in New Ad

The tobacco industry’s front group, “Californians Against Out-of-Control Taxes and Spending,” is spending millions to run a 30-second TV ad opposing Proposition 29, a ballot measure to increase in the state’s cigarette tax. The ad features an unlikely ally: a female, African-American doctor named LaDonna Porter, M.D. Prop. 29 would increase California’s 87-cent per pack cigarette tax by an additional $1.00 to fund cancer research, smoking reduction programs and enforcement of tobacco-related laws. In the ad, Porter, stands in an examination room wearing a white lab coat and says she’s against smoking, but she finds Proposition 29 flawed. “Not one penny” of the funds generated by the measure will go towards new funding for cancer treatment, Porter says, and she raises the specter that the money could be spent out of state. The ad is consistent with the tobacco industry’s longtime strategy of getting doctors to endorse their products and back their favored policies. Still, it has generated outrage. The African American Tobacco Control Leadership Council in Oakland, California sent a scathing open letter to Dr. Porter expressing shock and outrage that she is working for Big Tobacco. It’s not the first time Dr. Porter has worked for Big Tobacco. In 2006, as LaDonna White, she starred in a tobacco industry-backed ad opposing Proposition 86, yet another measure to increase taxes on cigarettes and chewing tobacco. Dr. Porter has also lent her credibility to the pharmaceutical industry to fight an initiative that would have put a dent in drug companies’ profits.

Citizens Battle Telecomm Lobby in DeKalb County, Georgia

A cell phone tower fire in Georgia in Dec. 2011 that required two homes and a daycare center to be evacuated. Photo credit: CBSAtlanta.com

After residents of DeKalb County, Georgia actively opposed plans by T-Mobile  and AT&T to build telecommunications towers on the grounds of eight local public schools, Georgia State Representative Karla Drenner stepped up to the plate to help out. Rep. Drenner introduced HB 1197,  “Cell Phone Towers in DeKalb County,” that would ban placing cellphone towers on public school grounds unless the cellular carrier can show that there is an absolute need for the tower, and that the location sought on school grounds is the only location that can adequately provide service to satisfy that need. Sixteen out of 18 DeKalb County representatives signed on to support the local bill. Support for the measure crossed political, racial and geographic lines. Citizens in favor of the bill also got support from all of their county commissioners and collected over 1,200 signatures on petitions supporting the measure — an admirable number considering Chuck Sims’ represents a county of only 380 people. A legislative committee heard three hours of testimony about the bill over three days at three separate state hearings, and not one person showed up to say they were in favor of plans to put the towers on school grounds. With support like that, the bill should have passed easily through the committee and moved to the House floor. But it didn’t. Why?

How to Search Online Tobacco Industry Documents

A video by Marty Otañez, Assistant Professor, Anthropology Department, University of Colorado, Denver

Smoking Gun from Marty Otañez on Vimeo.

Watch another episode in a series of episodes on the practices of tobacco companies. The series of short videos highlights tobacco industry documents research using the online Legacy Tobacco Documents Library (http://legacy.library.ucsf.edu) and British American Tobacco Documents Archive (http://bat.library.ucsf.edu)

Anne Landman, special guest

Marty Otañez, Assistant Professor, Anthropology Department, University of Colorado, Denver
www.sidewalkradio.net
www.dscoalition.org
www.fairtradetobacco.org

Can Wall Street Fund Universal Healthcare in U.S.?

National Nurses United support a tiny financial transaction tax to pay for universal healthcare in the U.S.

Over a thousand activists including members of National Nurses United marched in New York City April 26 to demand the government levy a tiny tax — just 0.5 percent — on speculative financial trades to fund universal health care in the United States. The idea is to add a small sales tax to Wall Street transactions of stocks, dividends and other financial deals, just like the tax ordinary consumers pay when they buy goods at a department store. The proposed tax, just one-half of one percent, would amount to just 50 cents on every $100 worth of financial transactions, but it would add up to a huge amount of money: about $350 billion each year. The tax wouldn’t apply to ordinary consumer transactions like ATM use, debit card purchases or home loans, and traders would be barred from passing the costs of the tax on to consumers. The main targets of the a tax are the big financial firms whose risky trading led to the meltdown of the global economy, like Citibank, JP Morgan, Goldman Sachs and Morgan Stanley. These four firms alone account for almost a quarter of the entire global market volume on trades of currency. The tiny tax would take advantage of a huge increase in speculative financial activity over the past decade to benefit Americans’ access to health care. A financial transaction tax isn’t a new idea. The U.S. had such a tax in place from 1914 to 1966. The idea of a financial transaction tax is gaining acceptance has been endorsed by conservative presidents in France and Germany, as well as former United Nations Secretary General Kofi Annan.

BP Ads Say Everything’s Great in the Gulf; Fisherman Report Sicknesses, Deformed Sea Life

Tumors on Gulf shrimp

Two years after the Deepwater Horizon catastrophe in the Gulf of Mexico, BP is running ads on TV promoting tourism in the Gulf of Mexico. The ads say the seafood is great, the beaches are inviting and times have never been better down in the Gulf. But reports from people who live and fish in the Gulf aren’t so great. In fact, they’re scary. Fishermen report seeing wide-scale deformities in sea life, like shrimp without eyes, tumors on their heads, crabs with rotting shells and fish with sores on their bodies. One fisherman reported catching 400 pounds of eyeless shrimp. The harvest of brown shrimp has  decreased by two thirds and the white shrimp have been wiped out. Gulf families report that their children, who were well prior to the BP spill, now chronically suffer from diffuse illnesses, like inflamed sinuses, upset stomachs, rashes and allergies. Fishermen complain of  headaches, chronic cough, skin rashes, vomiting and diarrhea, and bleeding from ears and nose — and they have no money to pay for medical care. Some are seeking enough money from BP to enable them to leave the Gulf coast for good.

Philip Morris and Monsanto Sued over Birth Defects in Tobacco Farmers’ Children

Screen shot from Monsanto's website

Tobacco farmers in Argentina filed a lawsuit (pdf) against Monsanto and Philip Morris for requiring them to use herbicides and pesticides that caused a high rate of severe birth defects among their children. The farmers charge that Philip Morris and the subsidiary companies that bought their crops required the farmers to stop growing their native tobacco grow a new kind of tobacco instead that Philip Morris uses in its cigarette formulation for the North and South American markets. The new tobacco they had to grow required more pesticides, and the farmers had to use excessive amounts of Monsanto’s glyphosate-based herbicide Roundup — but the defendant companies did not warn them about the dangers of the herbicide, or provide the farmers with safety information about the chemical or any protective gear to wear when applying it.

“Clergy for Choice” Calls for 40 Days of Prayer for Abortion Rights

Logo of the Religious Coalition for Reproductive Choice

A religious group in Humboldt County, California is initiating a new, pro-choice grassroots movement in support of abortion rights called “40 Days of Prayer Supporting Women Everywhere.” Clergy for Choice offers a message of support for women dealing with reproductive issues, including pregnancy.  A 2-page, tri-fold brochure describing the effort (pdf) says, “We are religious leaders who value all human life. We trust you to decide about your sexuality & planning your family. Humboldt County Clergy are available to talk with you about the spiritual aspects of sexuality and reproductive choice.”  The back of the brochure lists daily prayers supporters are urged to make on each of the 40 days, like: Day 1: “Today we pray for women for whom pregnancy is not good news, that they know they have choices,” Day 11: “Today we pray for better access to all forms a birth control.” Day 22: “Today we pray for women in developing nations, that they may know the power of self-determination. May they have access to employment, education, birth control and abortion.”

FDA Orders Sexual Dysfunction Warning Added for Merck Baldness Drug Propecia

If your hairline is receding and you’re are thinking about taking Merck’s baldness drug Propecia, you might want to think again. The U.S. Food and Drug Administration (FDA) ordered drug maker Merck to change the warning labels for Propecia and its prostate drug Proscar to include “libido disorders, ejaculation disorders and orgasm disorders,” conditions that FDA notes may continue well after patients stop taking the drugs.  While FDA says it isn’t clear whether finasteride, the active chemical in Propecia and Proscar, is what causes the persistent sexual problems, side effects reported by those using the drugs “suggest a broader range of adverse effects than previously reported in patients taking these drugs.” FDA approved Proscar in 1992 and Propecia in 1997.  Since then, the agency has reviewed 421 post-marketing reports of sexual dysfunction from those taking Propecia between 1998 and 2011. Of those, 59 cases described sexual dysfunction lasting a minimum of three months after discontinuing Propecia. FDA reviewed 131 reports of similar problems associated with Proscar. In 2011, FDA ordered the warning labels of both product be revised to include erectile dysfunction that continues after patients stop taking the drug.  People can report adverse side effects of prescription drugs to FDA’s MedWatch hotline at 1-800-332-1088, report them online at MedWatch Online or through the U.S. mail using the MedWatch form (pdf) available at FDA’s website.

Source: U.S. Food and Drug Administration, April 11, 2012

NFL Players Promote Adult Diapers

NFL football players endorsing products for money isn’t new, but DeMarcus Ware of the Dallas Cowboys, Wes Welker of the New England Patriots and Clay Matthews of the Green Bay Packers have all agreed to try on “Depend” adult undergarments and promote them by wearing them on the field — and on camera — while running drills.  Kimberly-Clark, the maker of Depends, has a new ad campaign called the “Great American Try On,” in which American celebrities and sports icons wear the underwear in public in exchange for hefty donations to selected charities. Sexy actress Lisa Rinna appears in a new ad in which she announces she is wearing the company’s new “Silhouette” product under a slinky, form-fitting black dress while walking the red carpet with her husband. 

Johnson & Johnson Fined $1.2 Billion for Illegal Drug Marketing

The state of Arkansas has ordered Johnson & Johnson and one of its subsidiaries, Janssen Pharmaceuticals, to pay $1.2 billion in fines for deceptively marketing the antipsychotic drug Risperdal, approved to treat conditions like schizophrenia and bipolar disorder. The companies were accused of failing to provide adequate warning about potential side effects of the drug, which include diabetes, weight gain, neurological problems and increased risk of strokes and death in elderly patients with dementia.   Fletch Trammell, a lawyer in the case who had used Risperdal, said that J&J hid studies that showed Risperdal caused diabetes at a higher rate than a competing drug. The court also found nearly 240,000 instances in which the companies violated the state laws against Medicaid fraud, with each count representing one prescription for Risperdal written to a state Medicaid patient over a 3 1/2 year period. The fine for the Medicaid fraud portion of the case, at $5,000 per prescription, was the state’s minimum.  A 12 person jury deliberated for three hours before finding against J&J. Arkansas is just one of several states suing over Risperdal. South Carolina and Texas have already reached settlements with J&J in their lawsuits. J&J plans to appeal the Arkansas ruling, claiming it did not break the law and that the package insert that comes with the medication was approved by the U.S. Food and Drug Administration.

Main source: New York Times, April 11, 2012